Palatin Technologies
PTN
#10932
Rank
NZ$16.7 M
Marketcap
NZ$9.38
Share price
-4.10%
Change (1 day)
-60.85%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -NZ$14.63 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$13.18 Million. In 2025 the company made an earning of -NZ$17.53 Million, an increase over its 2024 earnings that were of -NZ$49.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$14.63 Million-16.5%
2025 -NZ$17.53 Million-64.29%
2024 -NZ$49.07 Million-16.9%
2023 -NZ$59.05 Million5.99%
2022 -NZ$55.71 Million-13.7%
2021 -NZ$64.55 Million33.25%
2020 -NZ$48.44 Million-172.11%
2019 NZ$67.17 M2352.33%
2018 NZ$2.73 M-94.13%
2017 NZ$46.67 M-154.92%
2016 -NZ$84.99 Million3.67%
2015 -NZ$81.98 Million878%
2014 -NZ$8.39 Million-72.64%
2013 -NZ$30.64 Million-33.11%
2012 -NZ$45.8 Million77.71%
2011 -NZ$25.78 Million
2003 -NZ$43.65 Million29.93%
2002 -NZ$33.59 Million36.18%
2001 -NZ$24.67 Million
1999 -NZ$20.48 Million6.04%
1998 -NZ$19.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.09 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$27.48 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$1.57 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.58 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.11 B-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.22 Billion 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.28 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$53.71 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$0.11 Billion 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA